Watertown, MA, United States

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

WATERTOWN, Mass., Oct. 16, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the…

2024-10-16 11:00

Lyra Therapeutics Fully Enrolls Pivotal Phase 3 ENLIGHTEN 2 Trial of LYR-210 for the Treatment of Chronic Rhinosinusitis

-- Topline Results Expected Q2 2025 -- WATERTOWN, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), a clinical-stage biotechnology company developing long-acting anti-inflammatory therapies for the loca…

2024-10-15 11:00

Motus GI (NASDAQ:MOTS) vs. Lyra Therapeutics (NASDAQ:LYRA) Critical Survey

Motus GI (NASDAQ:MOTS – Get Free Report) and Lyra Therapeutics (NASDAQ:LYRA – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, ana…

2024-10-13 05:54

Disc Medicine (NASDAQ:IRON) versus Vistagen Therapeutics (NASDAQ:VTGN) Head to Head Review

Vistagen Therapeutics (NASDAQ:VTGN – Get Free Report) and Disc Medicine (NASDAQ:IRON – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional owners…

2024-10-11 10:11